Clinical Trial Update: Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment Elevation [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of a platelet aggregation inhibitor in patients with non-ST-elevation acute coronary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st-elevation Acute Coronary Syndrome

Snippet

Sponsor: Sanofi | Conditions: Platelet Aggregation Inhibitors, NSTEACS | Phase 3 | Status: COMPLETED